The startup plans to use the funds to continue expanding its commercialization and to conduct research that could help extend the age group the system can diagnose. The company's technology is currently used by eight clinicians across six states in the U.S. The CEO, Tom Ressemann, highlighted the growing interest in the autism-focused healthcare space from venture capitalists, attributing this to increased awareness of the condition's prevalence.
Key takeaways:
- EarliTec Diagnostics has raised $21.5 million in a Series B round to expand its system that uses AI to diagnose autism in children as young as 16 months old.
- The startup's technology involves a child watching videos and social interactions on a screen for 12 minutes while the device tracks their eye movements, with the premise that children with autism won't focus on the video the same way that kids without autism will.
- Currently, the technology is used by eight clinicians across six states in the U.S. The funds will be used to expand its commercialization and improve assessment and treatment options.
- There is growing interest in the autism-focused healthcare space from venture capitalists, with several firms and startups raising significant funds for neurodiverse solutions.